Argos Therapeutics (ARGS) Misses Q2 EPS by 5c

August 10, 2016 4:24 PM EDT
Get Alerts ARGS Hot Sheet
Trade ARGS Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Argos Therapeutics (NASDAQ: ARGS) reported Q2 EPS of ($0.48), $0.05 worse than the analyst estimate of ($0.43). Revenue for the quarter came in at $488.64 thousand versus the consensus estimate of $200 thousand.

For earnings history and earnings-related data on Argos Therapeutics (ARGS) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment